Michael Popiolek

8PUBLICATIONS
5CO-AUTHORS
Biomolecular modelling and designPharmaceutical delivery technologiesCharacterisation of biological macromoleculesMolecular medicineComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 18, 2024
Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M<sub>4</sub> Muscarinic Acetylcholine Receptor.

Christopher R Butler, Michael Popiolek, Laura A McAllister

|Jan 24, 2020
D1 Agonist Improved Movement of Parkinsonian Nonhuman Primates with Limited Dyskinesia Side Effects.

Damon Young, Michael Popiolek, Patrick Trapa

|Jul 10, 2019
Striatal, Hippocampal, and Cortical Networks Are Differentially Responsive to the M4- and M1-Muscarinic Acetylcholine Receptor Mediated Effects of Xanomeline.

Catherine A Thorn, Joshua Moon, Clinton A Bourbonais

|Nov 28, 2018
Striatal, Hippocampal, and Cortical Networks Are Differentially Responsive to the M4- and M1-Muscarinic Acetylcholine Receptor Mediated Effects of Xanomeline.

Catherine A Thorn, Joshua Moon, Clinton A Bourbonais

|Oct 19, 2018
In Vivo Modulation of Hippocampal Excitability by M4 Muscarinic Acetylcholine Receptor Activator: Implications for Treatment of Alzheimer's Disease and Schizophrenic Patients.

Michael Popiolek, Yael Mandelblat-Cerf, Damon Young

|Jun 13, 2018
Lack of Effect of Sodium Benzoate at Reported Clinical Therapeutic Concentration on d-Alanine Metabolism in Dogs.

Michael Popiolek, Brendan Tierney, Stefanus J Steyn

Pageof 2

Frequent Collaborators

4 joint publications

Christopher R Butter

1 joint publications

Jennifer E Davoren

1 joint publications

Laura A McAllister

1 joint publications

Michael A Brodney